Viemed Healthcare, Inc.VMDNASDAQ
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank27
3Y CAGR-29.1%
5Y CAGR-22.1%
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

3Y CAGR
-29.1%/yr
vs -19.5%/yr prior
5Y CAGR
-22.1%/yr
Recent deceleration
Acceleration
-9.6pp
Decelerating
Percentile
P27
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
20257.90%
202420.00%
202327.77%
202222.18%
20214.04%
202027.49%
201946.26%
201852.86%
201747.05%
2016-17.76%